Am Fam Physician. 2006 Mar 15;73(6):974.

The article “Warfarin Therapy: Evolving Strategies in Anticoagulation” (February 1, 1999, page 635) incorrectly stated that the carboxylation of certain glutamic acid residues, which make clotting factors II, VII, IX, and X as well as anticoagulant proteins C and S biologically active, requires an oxidized vitamin K as a cofactor. The article should read, “This carboxylation process requires a reduced vitamin K as a cofactor.” The online version of this article has been corrected.


Copyright © 2006 by the American Academy of Family Physicians.
This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. Contact for copyright questions and/or permission requests.

Want to use this article elsewhere? Get Permissions


Sep 2021

Access the latest issue of American Family Physician

Read the Issue

Email Alerts

Don't miss a single issue. Sign up for the free AFP email table of contents.

Sign Up Now

Navigate this Article